Topics

Investment Plan for Europe: Successful launch of Tech Transfer Fund “KHAN-I”

03:00 EDT 13 Sep 2019 | Bionity

Khanu Management GmbH (Khanu), a drug discovery focused fund management team, announces the successful launch of KHAN Technology Transfer Fund I GmbH & Co KG (KHAN-I), based in Dortmund, Germany. The European Investment Fund (EIF, Luxemburg), the Austria Wirtschaftsservice GmbH (Vienna, Austria) and...

Original Article: Investment Plan for Europe: Successful launch of Tech Transfer Fund “KHAN-I”

NEXT ARTICLE

More From BioPortfolio on "Investment Plan for Europe: Successful launch of Tech Transfer Fund “KHAN-I”"

Quick Search

Relevant Topic

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...